Navigation Links
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Germany & Austria
Date:5/13/2009

SAN DIEGO, May 13 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical device company, today announced that it has established a distribution partnership for the German and Austrian markets through Krainer Medtechnik, a Vienna-based firm specializing in the marketing and distribution of innovative medical devices.

Michel Vaudry, SpectraScience's VP Sales and Marketing, commented, "We are pleased to add another distribution partner in Europe. Krainer Medtechnik is a respected and well-established medical distribution company and its decision to add the WavSTAT Optical Biopsy System to their portfolio is a strong validation of the need for our technology. Krainer was established in 1979 and distributes other leading gastroenterological diagnostics products from market leaders including Alpine Biomed, Medtronic Functional Diagnosis, Spirus, Horizons, IntroMedic, and Sierra."

Krainer Medtechnik's President & Managing Director, Guido Carniolan, stated that, "We are pleased to be SpectraScience's distribution partner and believe there is significant market potential for this innovative Gastro Intestinal cancer diagnostic system. With our strategy to be the leader in Gastro-Diagnostics, the WavSTAT Optical Biopsy System is an ideal fit into our program. We see important benefits to our physicians, enabling them to quickly distinguish between normal and precancerous tissue in the GI tract and allowing for physical biopsy at exactly the same site and time that the optical biopsy is performed. More importantly, the WavSTAT objectively identifies the borders of tissue during surgery to determine if all cancerous tissue has been removed. This will prevent a second surgery."

Vaudry added, "Mr. Carniolan is a respected thought leader in the healthcare market and his company's support of the WavSTAT System will be instrumental in our acceptance at the major gastroenterology centers in Germany and Austria. Krainer Medtechnik is a perfect partner for SpectraScience as we move our business forward."

This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-KSB and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically scan tissue and provides the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use. In addition, the Company's LUMA(R) Cervical Imaging technology has received FDA approval as an optical non-invasive system that is proven to more effectively detect cervical cancer precursors than conventional methods available today.

    Contact:
    SpectraScience, Inc.                          Hayden Communications
    Jim Hitchin, Chief Executive Officer          Investor Relations
    (858) 847-0200 x 201                          Todd Pitcher
   http://www.spectrascience.com                 (858)-518-1387


'/>"/>
SOURCE SpectraScience, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SpectraScience CEO Jim Hitchin Featured in Interview With The Wall Street Transcript
2. SpectraScience Awarded Patent for Its Optical Biopsy System and Methods for Tissue Diagnosis
3. SpectraScience Strengthens Leadership Team With Four Key Hires
4. Jim Dorst Joins SpectraScience as CFO
5. SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
6. Sinobiopharma Secures Rights to Seven Key Patents
7. Aerovance Secures $38 Million in Equity Financing
8. VIA Pharmaceuticals Secures Financing Up to $10.0 Million
9. Pearl Therapeutics Secures $8 Million in Debt Financing
10. Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
11. Sopherion Therapeutics Secures $55 Million in Series C Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
(Date:2/23/2017)... , ... February 23, 2017 ... ... announced today that in a published evaluation of multiple immunoassay-based threat detection ... Department of Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found ...
(Date:2/23/2017)... ... February 23, 2017 , ... David Nolte, PhD accepted Purdue ... Purdue Research Park of West Lafayette, Indiana. , The top commercialization ... to, and success with, commercializing discoveries from Purdue research. “This award is truly ...
(Date:2/23/2017)... ... , ... Today, researchers can fast-track sample collection and analysis ... biomarkers or SNPs of interest) using one, easy-to-collect saliva sample. With the addition ... insulin and other relevant biomarkers can be extensively studied through a non-invasive sample ...
Breaking Biology Technology:
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017 /PRNewswire/ ... of Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, ... study that will apply the power of IBM cognitive ... and health centers. By analyzing data streaming from sensors ... into physical and environmental conditions, and obtain deeper learnings ...
(Date:2/21/2017)... , February 21, 2017 Der ... US-Dollar wachsen. Nach einem Gespräch mit mehr als 50 Vertretern ... Hindernisse zu überwinden gilt, um diese Prognose zu realisieren. ... ... die Mobilisierung der finanziellen Mittel für die Biobank, die ...
Breaking Biology News(10 mins):